|
Feb 12
|
CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates
|
|
Feb 11
|
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 11
|
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 10
|
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
|
|
Dec 30
|
Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?
|
|
Dec 29
|
CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?
|
|
Sep 25
|
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
|
|
Sep 5
|
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
|
|
Sep 4
|
Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?
|
|
Sep 2
|
3 Monster Biotech Stocks to Buy Before 2025
|
|
Aug 26
|
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
|
Jul 29
|
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 24
|
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
|
|
Jul 23
|
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jul 23
|
Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?
|
|
Jul 22
|
3 Gene Editing Stocks Shaping the Future of Medicine
|
|
Jul 11
|
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
|
|
Jul 10
|
Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market Today
|
|
Jun 12
|
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
|
|
May 15
|
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
|